ARTICLE | Clinical News
Hybridon preclinical data
September 16, 1996 7:00 AM UTC
Regression of human colon carcinoma in SCID mice was slowed by the agents, prepared by HYBN to target the RI-alpha subunit of cyclic-AMP-dependent protein kinase ( protein kinase A). As reported at th...